Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting267%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients

NCT07259278
recruitingnot_applicable

Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease

NCT07031531
completednot_applicable

Artificial Intelligence-Enhanced Management for Coronary Heart Disease (AIM-CHD) : Impact on Cholesterol and Other CHD Risk Factors

NCT06686056

Clinical Trials (3)

Showing 3 of 3 trials
NCT07259278Not Applicable

Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients

Recruiting
NCT07031531Not Applicable

Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease

Recruiting
NCT06686056Not Applicable

Artificial Intelligence-Enhanced Management for Coronary Heart Disease (AIM-CHD) : Impact on Cholesterol and Other CHD Risk Factors

Completed

All 3 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
3